FR2278325A1 - Complexe renfermant un antibiotique - Google Patents

Complexe renfermant un antibiotique

Info

Publication number
FR2278325A1
FR2278325A1 FR7425203A FR7425203A FR2278325A1 FR 2278325 A1 FR2278325 A1 FR 2278325A1 FR 7425203 A FR7425203 A FR 7425203A FR 7425203 A FR7425203 A FR 7425203A FR 2278325 A1 FR2278325 A1 FR 2278325A1
Authority
FR
France
Prior art keywords
penicillin
cephalosporin
syrups
oral administration
resin complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7425203A
Other languages
English (en)
French (fr)
Other versions
FR2278325B1 (xx
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to FR7425203A priority Critical patent/FR2278325A1/fr
Publication of FR2278325A1 publication Critical patent/FR2278325A1/fr
Application granted granted Critical
Publication of FR2278325B1 publication Critical patent/FR2278325B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7425203A 1974-07-19 1974-07-19 Complexe renfermant un antibiotique Granted FR2278325A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7425203A FR2278325A1 (fr) 1974-07-19 1974-07-19 Complexe renfermant un antibiotique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7425203A FR2278325A1 (fr) 1974-07-19 1974-07-19 Complexe renfermant un antibiotique

Publications (2)

Publication Number Publication Date
FR2278325A1 true FR2278325A1 (fr) 1976-02-13
FR2278325B1 FR2278325B1 (xx) 1978-07-28

Family

ID=9141501

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7425203A Granted FR2278325A1 (fr) 1974-07-19 1974-07-19 Complexe renfermant un antibiotique

Country Status (1)

Country Link
FR (1) FR2278325A1 (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005864A1 (fr) * 1994-08-24 1996-02-29 Hi Pharmtech Forme pharmaceutique solide pour l'administration d'une substance active liquide liposoluble

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005864A1 (fr) * 1994-08-24 1996-02-29 Hi Pharmtech Forme pharmaceutique solide pour l'administration d'une substance active liquide liposoluble
FR2723846A1 (fr) * 1994-08-24 1996-03-01 Hi Pharmtech Forme pharmaceutique solide pour l'administration d'une substance active liquide liposoluble

Also Published As

Publication number Publication date
FR2278325B1 (xx) 1978-07-28

Similar Documents

Publication Publication Date Title
CA967668A (en) Method and apparatus for producing magazines or the like
AU453389B2 (en) Buffing and deburring machine
AU2140492A (en) Use of hemoglobin in a method for the treatment of tumors with chemotherapeutic agents
AU1589183A (en) Carbapenem antibiotics
AU6119680A (en) Beta-lactam antibiotics
CA1010848A (en) Cephalosporin complexes and process for producing cephalosporin antibiotics therefrom
AU572090B2 (en) Carbapenem antibiotics
FR2278325A1 (fr) Complexe renfermant un antibiotique
CA976494A (en) Antibiotiques 23.671 rp et 23.672 r.p. de streptomyces chryseus
AU510252B2 (en) N-acetyl thienamycin type antibiotics
AU3192077A (en) Penicillins and cephalosporin antibiotics
DE3365979D1 (en) Beta-lactam antibiotics, process for their preparation and their use as medicines
AU456549B2 (en) 1-substituted 6-phenyl-4h-2-triazolo [4,3-2] [1,4] benzodiazepines and the production thereof
CA976707A (en) Traveling pneumatic cleaner and method
AU4691189A (en) Polyether resins, and process for preparing the same
AU1763583A (en) Antibiotic m 9026 and associated factors 1, 2 and 3
CA996104A (en) Antibiotic 9-acyl-3"-thiomethoxymethyl-sf-837 substance and process for preparing the same
CA989842A (en) 2-mercapto-pyrido(1,2-6)1,2,4-thiodiazolium salts and derivatives thereof
CA977758A (en) Exo-2-phenyl-bicyclo-(2,2,1)-heptane-2-(n-methyl-piperidol-4-)-carbonic-acid-ester and salts thereof
AU1398183A (en) Beta-lactam antibiotics
CA1008077A (en) 1,2,3-triazoles and process for their preparation
AU463529B2 (en) Cephalosporin derivatives and process fob the preparation thereof
DE3071645D1 (en) Beta-lactam antibiotics, their preparation and use
JPS5740486A (en) Beta-lactam antibiotic, manufacture and use
CA931879A (en) Arrangement in disk-formed body, in particular in a record

Legal Events

Date Code Title Description
ST Notification of lapse